Effect of Ultra-gyn® on Vulvovaginal Candidiasis - Trial NCT05273333
Access comprehensive clinical trial information for NCT05273333 through Pure Global AI's free database. This phase not specified trial is sponsored by Biocodex and is currently Recruiting. The study focuses on Vulvovaginal Candidiasis, Genital. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Biocodex
Timeline & Enrollment
N/A
Feb 23, 2022
Dec 01, 2022
Primary Outcome
To assess the effect of Ultra-gyn® in relieving the symptoms of Vulvovaginal Candidiasis
Summary
The aim of this post-market clinical follow up study is to confirm the performance and the
 safety of Ultra-gyn® (when used in accordance with its approved labelling)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05273333
Device Trial